← Back to all trials
Not Yet Recruiting
NCT07797946
Preoperative Ivabradine Doses for Hemodynamic Stability in FESS
Conditions: Hemodynamic Instability
Sex: All
Ages: 21 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Minia University
Summary
This study compares two different preoperative doses of a heart-rate-lowering medication called ivabradine in patients undergoing endoscopic sinus surgery under general anesthesia. Patients will receive either a lower dose, a higher dose, or a placebo (inactive pill) before surgery. The goal is to see which approach best keeps blood pressure and heart rate stable during surgery, and whether it reduces bleeding and improves the surge
Eligibility Criteria
Inclusion Criteria:
* Age between 21 and 60 years of both sexes
* ASA physical status I or II
* Baseline heart rate ≥ 70 beats per minute in sinus rhythm on preoperative ECG
Exclusion Criteria:
* Patient refusal or inability to provide informed consent
* Baseline heart rate \
Source: ClinicalTrials.gov (NCT07797946). StuddyBuddy aggregates publicly available trial information.
